Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03008980 · ClinicalTrials.gov registry record
WATS3D for the Detection of Esophageal Dysplasia
A clinical trial, sponsored by CDx Diagnostics.
- Completed
- Registry status
- 160
- Enrollment target
NCT03008980 is a clinical trial that has completed, run by CDx Diagnostics. The registered enrollment target is 160 participants.
The verdict
NCT03008980 has completed, sponsored by CDx Diagnostics.
- COMPLETED
- Registry status
- 160 participants
- Enrollment target
Study Summary
Patients will be recruited from participating institutions prior to planned routine care EGD with WATS3D brush samples and forceps biopsies. Eligibility will be reviewed and patients who are potentially eligible for the study will be approached regarding the study. If interested, participants will be consented and proceed with routine care EGD. The study coordinator or other research personnel will document information from the routine care endoscopy as part of this research study. Follow-up information collected will include WATS3D cytology and forceps biopsy pathology results from any routine care endoscopy performed during the course of participation in the study, any surgeries received and related to their condition, and any other care received as part of their condition. WATS3D samples will be sent to CDx Diagnostics for analysis.
Interventions
- OTHER Diagnostic Test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2014-05 |
| Est. Completion | 2018-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03008980
The ClinicalTrials.gov registry entry for NCT03008980 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is CDx Diagnostics, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Diagnostic Test is the first listed.
NCT03008980 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03008980 about?
NCT03008980 is a clinical study titled "WATS3D for the Detection of Esophageal Dysplasia". Patients will be recruited from participating institutions prior to planned routine care EGD with WATS3D brush samples and forceps biopsies. Eligibility will be reviewed and patients who are potentially eligible for the study will be approached regarding the study. If interested, participants will b...
What is the current status of trial NCT03008980?
This trial is currently completed. The enrollment target is 160 participants. The study started on 2014-05. Estimated completion is 2018-12.
What interventions are being tested in trial NCT03008980?
The interventions under investigation include: Diagnostic Test (OTHER).
Who is sponsoring clinical trial NCT03008980?
This trial is sponsored by CDx Diagnostics, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.